The international market for Active Pharmaceutical Ingredient (API) producers is a intricate landscape, covering numerous locations. The People’s Republic of China currently dominates the output of APIs, second to India, which is a key player in both off-patent API provision . European businesses, particularly in places like Germany, Switzerland,